International Journal of Infectious Diseases: Volume 102 to Volume 113
International Journal of Infectious Diseases (IJID) Overview
The International Journal of Infectious Diseases (IJID) stands as a prominent academic platform, championed by the International Society for Infectious Diseases. Published monthly, IJID is dedicated to shedding light on the multifaceted dimensions of infectious diseases, emphasizing those prevalent in resource-limited settings.
- Open Access & Peer-Reviewed: Ensuring the free dissemination of knowledge, IJID offers unrestricted access to its rich content, which undergoes meticulous peer-review, maintaining the highest standards of academic rigor.
- Clinical and Laboratory-Based Research: IJID delves into both the clinical implications and laboratory facets of infectious diseases, ensuring a comprehensive understanding of these maladies.
- Clinical Trials: Reports detailing clinical trials find a notable space in the journal, offering evidence-based insights into the effectiveness of various interventions.
- Reviews: IJID features exhaustive reviews that synthesize existing knowledge, highlighting breakthroughs and identifying gaps in the field.
- Epidemiology & Control: The journal underscores the epidemiological patterns of infectious diseases, coupled with strategies to control their spread, especially in regions where resources are scarce.
- Disease Diagnosis & Treatment: IJID offers cutting-edge research on clinical diagnosis techniques and treatments, aiding practitioners and researchers alike.
- Case Reports: While the journal predominantly features original research and reviews, selected case reports that offer novel insights into infectious diseases are also published.
The IJID, under the aegis of the International Society for Infectious Diseases, aspires to be a frontrunner in the dissemination of knowledge about infectious diseases. It endeavors to be an invaluable resource for clinicians, researchers, policy-makers, and academicians, especially those working in areas where resources are limited. By spotlighting diseases common in such regions, the journal plays a pivotal role in advocating for global health equity, ensuring that the most vulnerable populations are not left behind in the quest for health and well-being.
In essence, the International Journal of Infectious Diseases serves as a beacon in the global health landscape, illuminating the path towards understanding, diagnosing, treating, and controlling infectious diseases worldwide.
Volume 102: Pages 1-590 (January 2021)
Volume 103: Pages 1-654 (February 2021)
Volume 104: Pages 1-754 (March 2021)
Volume 105: Pages 1-784 (April 2021)
Volume 106: Pages 1-430 (May 2021)
Volume 107: Pages 1-310 (June 2021)
Volume 108: Pages 1-616 (July 2021)
Volume 109: Pages 1-324 (August 2021)
Field Epidemiology: The Complex Science Behind Battling Acute Health Threats
The publication of this supplement is supported by Cooperative Agreement number NU2HGH000044, managed by TEPHINET (a program of The Task Force for Global Health) and funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, The Task Force for Global Health, Inc., or TEPHINET
Volume 110, Supplement 1, Pages S1-S76 (October 2021)
Volume 110: Pages 1-488 (September 2021)
Volume 111: Pages 1-362 (October 2021)
Volume 112: Pages 1-362 (November 2021)
Commemorating World Tuberculosis Day March 24th, 2021: “The Clock is Ticking”
The publication of this supplement is supported by an unrestricted educational grant from QIAGEN Sciences Inc.
Volume 113, Supplement 1, Pages S1-S104 (December 2021)